1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Gerresheimer AG
  6. News
  7. Summary
    GXI   DE000A0LD6E6

GERRESHEIMER AG

(GXI)
  Report
Real-time Estimate Tradegate  -  05/24 01:50:10 am EDT
67.48 EUR   -0.70%
05/16Gerresheimer AG Executes on Its Growth Strategy in Emerging Markets Boosting Capacities in India
CI
05/16GERRESHEIMER AG : Gerresheimer executes on its growth strategy in Emerging Markets boosting capacities in India
EQ
05/11GERRESHEIMER AG : Berenberg reaffirms its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Gerresheimer AG: Gerresheimer successfully issues promissory loan - transaction again significantly oversubscribed

11/23/2021 | 09:03am EDT


DGAP-Media / 23.11.2021 / 15:01

Gerresheimer successfully issues promissory loan - transaction again significantly oversubscribed

Duesseldorf, November 23, 2021 - Gerresheimer AG has reached another milestone in the realization of its financing strategy by successfully issuing a new promissory loan. The total volume amounts to EUR 150 m, with the funds helping the company to further improve its financing costs. The transaction was once again significantly oversubscribed due to favorable conditions.

On November 23, 2021, Gerresheimer AG concluded the placement of a new promissory loan to refinance several tranches from previous transactions. Once again, the company managed to improve the already favorable financing conditions. "Gerresheimer remains firmly on a course of profitable, sustainable growth," said Gerresheimer AG Chief Financial Officer, Dr. Bernd Metzner. "Many investors are convinced by our robust business model and want to participate in our long-term success. The new, significantly oversubscribed promissory loan replaces previous obligations while achieving a further improvement in the terms and conditions."

The promissory loan tranches have terms of three and five years and feature fixed and variable rates of interest. The funds from the promissory loans will be used to settle the repayments due in 2022 of certain tranches from previous promissory loan transactions. Repayments for the refinanced promissory loans will be disbursed in September 2022 and November 2022. Up until this point, proceeds from the current promissory loan issue will be utilized to reduce the drawdown on the Gerresheimer AG revolving credit facility. The transaction was supervised by Commerzbank, Landesbank Baden-Württemberg, and UniCredit.

Press contact
Jens Kürten
Group Senior Director Communication & Marketing
T +49 211 6181-250
jens.kuerten@gerresheimer.com

Investor Relations contact
Carolin Nadilo
Corporate Director Investor Relations
T +49 211 6181-220
carolin.nadilo@gerresheimer.com

About Gerresheimer
Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than ?1.4 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.



End of Media Release


Issuer: Gerresheimer AG
Key word(s): Finance

23.11.2021 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Gerresheimer AG
Klaus-Bungert-Str. 4
40468 Düsseldorf
Germany
Phone: +49-(0)211/61 81-314
Fax: +49-(0)211/61 81-121
E-mail: carolin.nadilo@gerresheimer.com
Internet: http://www.gerresheimer.com
ISIN: DE000A0LD6E6
WKN: A0LD6E
Indices: MDAX (Aktie)
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1251389

 
End of News DGAP Media

1251389  23.11.2021 

fncls.ssp?fn=show_t_gif&application_id=1251389&application_name=news&site_id=zonebourse_sftp

© EQS 2021
All news about GERRESHEIMER AG
05/16Gerresheimer AG Executes on Its Growth Strategy in Emerging Markets Boosting Capacities..
CI
05/16GERRESHEIMER AG : Gerresheimer executes on its growth strategy in Emerging Markets boostin..
EQ
05/11GERRESHEIMER AG : Berenberg reaffirms its Buy rating
MD
05/09Gerresheimer and Portal Enter Strategic Partnership to Treat Chronically Ill Patients w..
CI
05/09GERRESHEIMER AG : Gerresheimer and Portal enter strategic partnership to treat chronically..
EQ
04/13GERRESHEIMER AG : Credit Suisse reiterates its Buy rating
MD
04/12GERRESHEIMER AG : JP Morgan gives a Neutral rating
MD
04/11GERRESHEIMER AG : Gets a Buy rating from Deutsche Bank
MD
04/08GERRESHEIMER AG : Deutsche Bank keeps its Buy rating
MD
04/07GLOBAL MARKETS LIVE : Airbus, Berkshire Hathaway, Meta, Samsung, Tesla...
More news
Analyst Recommendations on GERRESHEIMER AG
More recommendations
Financials
Sales 2022 1 687 M 1 803 M 1 803 M
Net income 2022 117 M 125 M 125 M
Net Debt 2022 1 050 M 1 122 M 1 122 M
P/E ratio 2022 18,4x
Yield 2022 1,96%
Capitalization 2 134 M 2 280 M 2 280 M
EV / Sales 2022 1,89x
EV / Sales 2023 1,75x
Nbr of Employees 10 625
Free-Float 100%
Chart GERRESHEIMER AG
Duration : Period :
Gerresheimer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GERRESHEIMER AG
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 67,95 €
Average target price 92,11 €
Spread / Average Target 35,6%
EPS Revisions
Managers and Directors
Dietmar Siemssen Chief Executive Officer
Bernd Metzner Chief Financial Officer
Axel Herberg Chairman-Supervisory Board
Theodor Stuth Member-Supervisory Board
Udo Johannes Vetter Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
GERRESHEIMER AG-19.78%2 280
ABBOTT LABORATORIES-18.27%198 277
MEDTRONIC PLC0.78%137 548
BECTON, DICKINSON AND COMPANY4.57%71 922
HOYA CORPORATION-22.41%37 902
BAXTER INTERNATIONAL INC.-14.53%36 873